BAE Systems Purchases Cardiac Science AEDs and Training for Its U.S. Facilities IRVINE, Calif., Jan. 10 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving automatic public-access defibrillators (AEDs), today announced that Rockville, MD-based BAE Systems, one of America's foremost national security, aerospace and information systems companies, has purchased Powerheart(R) G3 AEDs for 37 of its facilities nationwide. In addition, BAE Systems has procured the associated AED/CPR training and program management for approximately 500 of its employees. BAE Systems Technology Solutions, a sector of BAE Systems North America, plans to outfit administrative, research and industrial locations with the devices, protecting more than 6,000 employees within their U.S. operations. Robert Murphy, president, BAE Systems Technology Solutions, said that the decision to deploy AEDs and train personnel makes perfect sense when you balance the minimal cost against the protection they provide. "We recognized the immeasurable value of installing defibrillators first hand this year when one of our colleagues was saved in a facility that happened to have an AED available and where coworkers had been trained in its use," said Murphy. "Our employees are our most valued asset and we intend to do everything we can to protect them in the workplace. Easily accessible defibrillators, such as the Powerheart G3, have been shown to dramatically increase cardiac arrest survival rates and we believe that this fact alone justifies our investment many times over." Raymond W. Cohen, Chairman and CEO of Cardiac Science, commented on the partnership by stating, "Company-wide deployments are becoming more commonplace as AED protection becomes part of the mindset in corporate settings both in the U.S. and abroad. It is rewarding to see more and more executives at top organizations making this commitment to employee safety and corporate risk management." About BAE Systems BAE Systems is an international company engaged in the development, delivery and support of advanced defense and aerospace systems in the air, on land, at sea and in space. The company designs, manufactures and supports military aircraft, surface ships, submarines, fighting vehicles, radar, avionics, communications, electronics and guided weapon systems. It is a pioneer in technology with a heritage stretching back hundreds of years. It is at the forefront of innovation, working to develop the next generation of intelligent defense systems. BAE Systems has major operations across five continents and customers in some 130 countries. The company has more than 90,000 people and generates annual sales of approximately $20 billion through its wholly-owned and joint venture operations. BAE Systems North America is one of America's foremost national security, aerospace and information systems companies. It is a leading provider of electronic and information-based systems and knowledge-based solutions that meet our customers' mission effectiveness and operational safety needs. BAE Systems North America employs more than 30,000 people at sites across the United States and the United Kingdom and generates more than $5 billion in annual sales. BAE Systems Technology Solutions Sector is a provider of tailored, integrated technical and professional services solutions for the U.S. DoD, Federal Civilian government, and Homeland Security markets. The sector delivers tailored discriminating solutions in the areas of Systems Engineering Technical Assistance (SETA), Operations & Maintenance/Range (O&M), Logistics, and Sub-system Integration. BAE Systems, innovating for a safer world. For further information contact: Paula Sandin, BAE Systems Technology Solutions Sector Tel: (301) 738-4653 Cell: (301) 233-1808 http://www.na.baesystems.com/ About Cardiac Science Cardiac Science develops, manufactures and markets Powerheart(R)-brand public-access defibrillators (AEDs) and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. The Company also makes the Powerheart(R) CRM(TM), the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms. In addition, its 55-person sales force in the U.S. and independent distributors in over 40 countries, Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies such as Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare. For more information, please visit http://www.cardiacscience.com/. This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, from time to time the company, or its representatives, have made or may make forward looking statements orally or in writing. The words "estimate," "potential," "intended," "expect," "anticipate," "believe," and similar expressions or words are intended to identify forward looking statements. Cardiac Science cautions that these statements are subject to substantial risks and uncertainties and are qualified by important factors that could cause actual results to differ materially from those reflected by the forward- looking statements and should not be relied upon by investors when making an investment decision. Information on these and other factors is detailed in the Company's Form 10-K for the year ending December 31, 2003, subsequent quarterly filings, and other documents filed by the Company with the Securities and Exchange Commission. Contact: Matt Clawson (Investors), or Michael Gioffredi Len Hall (Media) Chief Marketing Officer Allen & Caron Inc Cardiac Science, Inc. (949) 474-4300 (949) 797-3800 DATASOURCE: Cardiac Science, Inc. CONTACT: Investors, Matt Clawson, , or Media, Len Hall, , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Michael Gioffredi, Chief Marketing Officer of Cardiac Science, Inc., +1-949-797-3800, Web site: http://www.cardiacscience.com/ http://www.na.baesystems.com/

Copyright

Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Cardiac Science Charts.
Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Cardiac Science Charts.